Page 16 - Read Online

Pedica et al. Hepatoma Res 2021;7:71 https://dx.doi.org/10.20517/2394-5079.2021.89 Page 11 of 12

Financial support and sponsorship
None.

Conflicts of interest
Both authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Nagtegaal ID, Odze RD, Klimstra D, et al; WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours
of the digestive system. Histopathology 2020;76:182-8. DOI PubMed PMC
2. Cardinale V, Bragazzi MC, Carpino G, et al. Intrahepatic cholangiocarcinoma: review and update. Hepatoma Res 2018;4:20. DOI
3. Komuta M, Govaere O, Vandecaveye V, et al. Histological diversity in cholangiocellular carcinoma reflects the different
cholangiocyte phenotypes. Hepatology 2012;55:1876-88. DOI PubMed
4. Nakanuma Y, Sato Y, Ikeda H, et al. Intrahepatic cholangiocarcinoma with predominant "ductal plate malformation" pattern: a new
subtype. Am J Surg Pathol 2012;36:1629-35. DOI PubMed
5. Chua D, Chiow AKH, Ang TL, Wang LM. Malignant transformation arising within unusual and rare hepatic lesions: fibropolycystic
disease form of ductal plate malformation and biliary adenofibroma. Int J Surg Pathol 2018;26:542-50. DOI PubMed
6. Kaminsky P, Preiss J, Sasatomi E, Gerber DA. Biliary adenofibroma: a rare hepatic lesion with malignant features. Hepatology
2017;65:380-3. DOI PubMed
7. Nakanuma Y, Uesaka K, Kakuda Y, et al. Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and
molecular and genetic alterations. J Clin Med 2020;9:E3991. DOI PubMed PMC
8. Nakanishi Y, Nakanuma Y, Ohara M, et al. Intraductal papillary neoplasm arising from peribiliary glands connecting with the inferior
branch of the bile duct of the anterior segment of the liver. Pathol Int 2011;61:773-7. DOI PubMed
9. Schlitter AM, Jang KT, Klöppel G, et al. Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic,
immunohistochemical, and molecular analysis of 20 cases. Mod Pathol 2015;28:1249-64. DOI PubMed
10. Quigley B, Reid MD, Pehlivanoglu B, et al. Hepatobiliary mucinous cystic neoplasms with ovarian type stroma (so-called
"hepatobiliary cystadenoma/cystadenocarcinoma"): clinicopathologic analysis of 36 cases illustrates rarity of carcinomatous change.
Am J Surg Pathol 2018;42:95-102. DOI PubMed
11. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Geneva: World
Health Organization; 2010. DOI PubMed PMC
12. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and
cholangiocarcinoma. J Gastroenterol Hepatol 1996;11:758-64. DOI PubMed
13. Joseph NM, Tsokos CG, Umetsu SE, et al. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics
to hepatocellular carcinoma. J Pathol 2019;248:164-78. DOI PubMed
14. Beaufrère A, Calderaro J, Paradis V. Combined hepatocellular-cholangiocarcinoma: an update. J Hepatol 2021;74:1212-24. DOI
PubMed
15. Geramizadeh B, Gity R, Bahraini A, Malek-Hosseini SA. Synchronous hepatocellular carcinoma and cholangiocarcinoma in a patient
transplanted for cryptogenic cirrhosis. Int J Org Transplant Med 2014;5:125-8. PubMed PMC
16. Jain R, Fischer S, Serra S, Chetty R. The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas,
gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol 2010;18:9-15. DOI PubMed
17. Akiba J, Nakashima O, Hattori S, et al. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the
latest WHO classification. Am J Surg Pathol 2013;37:496-505. DOI PubMed
18. Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ. Expression of the stem cell factor receptor c-kit in normal and diseased
pediatric liver: identification of a human hepatic progenitor cell? Hepatology 1999;30:112-7. DOI PubMed
19. Nakamura H, Arai Y, Totoki Y, et al. Genomic spectra of biliary tract cancer. Nat Genet 2015;47:1003-10. DOI PubMed
20. Israel MA, Danziger N, McGregor KA, et al. Comparative genomic analysis of intrahepatic cholangiocarcinoma: biopsy type,
ancestry, and testing patterns. Oncologist 2021;25:1-10. DOI PubMed PMC
21. Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet 2021;397:428-44. DOI PubMed
22. Farshidfar F, Zheng S, Gingras MC, et al; Cancer Genome Atlas Network. Integrative genomic analysis of cholangiocarcinoma